Back to TSHA
Avoro Capital Advisors LLC → TSHA
Avoro Capital Advisors LLC TSHA Position History
Taysha Gene Therapies, Inc. • Healthcare
Quarters held
5
Latest value
$116.3M
Q3 2026
Peak value
$162.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $119.3M |
| Q4 2025 | $119.3M |
| Q1 2026 | $97M |
| Q2 2026 | $162.7M |
| Q3 2026 | $116.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $116.3M | 23.89M | — | — |
| Q2 2026 | $162.7M | 23.89M | — | — |
| Q1 2026 | $97M | 21.70M | — | — |
| Q4 2025 | $119.3M | 21.70M | — | — |
| Q4 2025 | $119.3M | 21.70M | — | — |
Other funds holding TSHA
$160.4M
$148.2M
$132.2M
$129.6M
$109M
$105.3M
$92.5M